Skip to main navigation Skip to search Skip to main content

Asymmetric synthesis and evaluation of α-quaternary chiral lactam derivatives as novel anticancer agents

  • Hwanhyuk Lee
  • , Su Jung Hwang
  • , Jisung Jung
  • , Suckchang Hong
  • , Myungmo Lee
  • , Hyeung Geun Park
  • , Hyo Jong Lee
  • , Yohan Park
  • Inje University
  • Seoul National University

Research output: Contribution to journalArticlepeer-review

Abstract

Asymmetric synthesis of α-quaternary chiral lactam derivatives as novel anticancer agents and evaluation of their cytotoxic potentials and spectrums are reported. Among the developed lactam derivatives, the most active new compounds (S)-4m and (S)-4n synthesized via asymmetric phase-transfer catalytic alkylation in very high optical yields (98 % ee) show promising in vitro anticancer activities with low micromolar IC50 values against colon, uterus, lung, and breast human cancer cells.

Original languageEnglish
Pages (from-to)1264-1270
Number of pages7
JournalArchives of Pharmacal Research
Volume37
Issue number10
DOIs
StatePublished - 1 Oct 2014
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anticancer activity
  • Breast cancers
  • Colon
  • Lung
  • Phase-transfer catalytic alkylation
  • α-Quaternary chiral lactam

Fingerprint

Dive into the research topics of 'Asymmetric synthesis and evaluation of α-quaternary chiral lactam derivatives as novel anticancer agents'. Together they form a unique fingerprint.

Cite this